Penetration of topically administered 0.5-percent caspofungin eye drops into human aqueous humor

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1761-1763

  Neoh, Chin Fen ^a   Leung, Lok ^b   Misra, Anant ^b,f   Vajpayee, Rasik B ^b,c   Davies, Geoffrey E ^d   Fullinfaw, Robert O ^e   Stewart, Kay ^a   Kong, David C M ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Health Systems Program Office   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f Southern Health ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; EYE DROPS;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; DOSAGE SCHEDULE COMPARISON; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; ELECTIVE SURGERY; EYE SURGERY; FEMALE; HUMAN; MALE; OCULAR PRURITUS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; ECHINOCANDINS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS;

EID: 79953205923     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01175-10     Document Type: Article

References (24)

1. Aydin, S., B. Ertugrul, B. Gultekin, G. Uyar, and E. Kir. 2007. Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy. BMC Infect. Dis. 7:87.
2. Bhartiya, P., M. Daniell, M. Constantinou, F. M. Islam, and H. R. Taylor. 2007. Fungal keratitis in Melbourne. Clin. Exp. Ophthalmol. 35:124-130.
3. Bours, J. 1990. The protein distribution of bovine, human and rabbit aqueous humour and the difference in composition before and after disruption of the blood/aqueous humour barrier. Lens Eye Toxic Res. 7:491-503.
4. Breit, S. M., et al. 2005. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am. J. Ophthalmol. 139:135-140.
5. Deresinski, S. C., and D. A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457.
6. Durand, M. L., et al. 2005. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am. J. Ophthalmol. 140:552-554.
7. Electronic Medicines Compendium. 9 March 2003, posting date. CANCIDAS (formerly Caspofungin MSD). Electronic Medicines Compendium, Datapharm Communications Ltd., Surrey, United Kingdom. http://www.medicines.org.uk /EMC/medicine/12843/SPC/CANCIDAS%20. Accessed 1 August 2010.
8. FlorCruz, N. V., and J. I. Peczon. 2008. Medical interventions for fungal keratitis. Cochrane Database Syst. Rev. 2008(1):CD004241. doi:10.1002/ 14651858.CD004241.pub2.
9. Gauthier, G. M., T. M. Nork, R. Prince, and D. Andes. 2005. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin. Infect. Dis. 41:e27-e28.
10. Goldblum, D., et al. 2007. Ocular penetration of caspofungin in a rabbit uveitis model. Graefes Arch. Clin. Exp. Ophthalmol. 245:825-833.
11. Goldblum, D., B. E. Frueh, G. M. Sarra, K. Katsoulis, and S. Zimmerli. 2005. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob. Agents Chemother. 49:1359-1363.
12. How, T. H., et al. 1998. Stability of cefazolin sodium eye drops. J. Clin. Pharm. Ther. 23:41-47.
13. Hurtado-Sarrió, M., et al. 2010. Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. Arch. Ophthalmol. 128:941-942.
14. Kernt, M., and A. Kampik. 19 February 2010, posting date. Intraocular caspofungin: in vitro safety profile for human ocular cells. Mycoses doi: 10.1111/j.1439-0507.2009.01853.x.
15. Lalitha, P., et al. 2007. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol. 125:789-793.
16. Manzouri, B., G. C. Vafidis, and R. K. Wyse. 2001. Pharmacotherapy of fungal eye infections. Expert Opin. Pharmacother. 2:1849-1857.
17. Neoh, C. F., et al. 2010. A rapid and sensitive liquid chromatography/mass spectrometry (LC/MS) assay for caspofungin in human aqueous humor. Antimicrob. Agents Chemother. 54:4467-4470.
18. Ozturk, F., et al. 2007. Efficacy of topical caspofungin in experimental Fusarium keratitis. Cornea 26:726-728. (Pubitemid 47080294)
19. Sarria, J. C., et al. 2005. Candida glabrata endophthalmitis treated successfully with caspofungin. Clin. Infect. Dis. 40:e46-e48.
20. Spriet, I., et al. 2009. Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. J. Antimicrob. Chemother. 64:877-878.
21. Srinivasan, M. 2004. Fungal keratitis. Curr. Opin. Ophthalmol. 15:321-327.
22. Tu, E. Y. 2009. Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. Cornea 28:116-119.
23. Vorwerk, C. K., et al. 2009. Aqueous humor concentrations of topically administered caspofungin in rabbits. Ophthalmic Res. 41:102-105.
24. Yildiran, S. T., et al. 2006. Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery. Med. Mycol. 44:665-669.